Moore Capital Management’s AEON Biopharma Inc AEON.WS Stock Holding History

Moore Capital Management’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-33,333	Closed	-$48.3K	–	583
2024 Q1	$48.3K	Hold	33,333	–	–	﹤0.01%	370
2023 Q4	$3.33K	Hold	33,333	–	–	﹤0.01%	402
2023 Q3	$5K	Hold	33,333	–	–	﹤0.01%	459
2023 Q2	$3K	Hold	33,333	–	–	﹤0.01%	491
2023 Q1	$2K	Hold	33,333	–	–	﹤0.01%	477
2022 Q4	$1.52K	Hold	33,333	–	–	﹤0.01%	522
2022 Q3	$2K	Hold	33,333	–	–	﹤0.01%	665
2022 Q2	$5K	Hold	33,333	–	–	﹤0.01%	679
2022 Q1	$10K	Hold	33,333	–	–	﹤0.01%	733
2021 Q4	$17K	Hold	33,333	–	–	﹤0.01%	723
2021 Q3	$18K	Hold	33,333	–	–	﹤0.01%	785
2021 Q2	$34K	Buy	+33,333	New	+$25.3K	﹤0.01%	802

Moore Capital Management's AEON.WS Position: Q2 2024 in Review

Moore Capital Management sold out of AEON Biopharma Inc (AEON.WS) in Q2 2024, closing a stake of 33,333 shares — an estimated $48.3K sold.

Moore Capital Management first reported a position in AEON.WS in Q2 2021 and held it in 12 quarters. The position peaked at $48.3K in Q1 2024. 0 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2024.

Moore Capital Management reported no remaining AEON Biopharma Inc position as of Q2 2024 after selling out during the quarter.
Moore Capital Management sold 33,333 AEON Biopharma Inc shares in Q2 2024, an estimated $48.3K.
Moore Capital Management first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 12 quarters.
Moore Capital Management's AEON Biopharma Inc position peaked at $48.3K in Q1 2024.
0 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2024.

Based on Moore Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.